DE3884200D1 - Verfahren zur Behandlung von Mastitis und anderen Staphylokokkeninfektionen. - Google Patents

Verfahren zur Behandlung von Mastitis und anderen Staphylokokkeninfektionen.

Info

Publication number
DE3884200D1
DE3884200D1 DE88308667T DE3884200T DE3884200D1 DE 3884200 D1 DE3884200 D1 DE 3884200D1 DE 88308667 T DE88308667 T DE 88308667T DE 3884200 T DE3884200 T DE 3884200T DE 3884200 D1 DE3884200 D1 DE 3884200D1
Authority
DE
Germany
Prior art keywords
mastitis
procedures
treatment
staph infections
staph
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88308667T
Other languages
English (en)
Other versions
DE3884200T2 (de
Inventor
Peter Blackburn
June Pollack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Microbiology Inc
Original Assignee
Applied Microbiology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA000575957A external-priority patent/CA1330758C/en
Application filed by Applied Microbiology Inc filed Critical Applied Microbiology Inc
Publication of DE3884200D1 publication Critical patent/DE3884200D1/de
Application granted granted Critical
Publication of DE3884200T2 publication Critical patent/DE3884200T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE88308667T 1988-08-29 1988-09-19 Verfahren zur Behandlung von Mastitis und anderen Staphylokokkeninfektionen. Expired - Fee Related DE3884200T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA000575957A CA1330758C (en) 1988-08-29 1988-08-29 Method of treating mastitis and other staphylococcal infections
EP88308667A EP0359873B1 (de) 1988-08-29 1988-09-19 Verfahren zur Behandlung von Mastitis und anderen Staphylokokkeninfektionen

Publications (2)

Publication Number Publication Date
DE3884200D1 true DE3884200D1 (de) 1993-10-21
DE3884200T2 DE3884200T2 (de) 1994-02-03

Family

ID=25672088

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88308667T Expired - Fee Related DE3884200T2 (de) 1988-08-29 1988-09-19 Verfahren zur Behandlung von Mastitis und anderen Staphylokokkeninfektionen.

Country Status (3)

Country Link
EP (1) EP0359873B1 (de)
AU (1) AU623864B2 (de)
DE (1) DE3884200T2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0405315B1 (de) * 1989-06-30 1995-08-23 American Cyanamid Company Verwendung eines phagozytise-aktievierenden Stoffes : LPS oder IL-2 zur Herstellung eines Arzneimittels zur Behandlung von Staphylococcus-aureus-Infektionen bei Kühen
US5342612A (en) * 1991-12-20 1994-08-30 American Cyanamid Company Compositions for the treatment of mammalian diseases
TW299310B (de) 1993-05-18 1997-03-01 Ciba Geigy Ag
EP0789581B1 (de) * 1993-08-20 2001-06-13 Novartis AG Verfahren zur prävention und behandlung der rindermastitis
US5762948A (en) * 1995-06-07 1998-06-09 Ambi Inc. Moist bacteriocin disinfectant wipes and methods of using the same
JP2001510805A (ja) * 1997-07-23 2001-08-07 アンビィー インコーポレイテッド リソスタフィン単独含有もしくは抗生物質併用ブドウ球菌感染症治療用薬剤組成物
US7232576B2 (en) 1997-10-31 2007-06-19 New Horizons Diagnostics Corp Throat lozenge for the treatment of Streptococcus Group A
US6428784B1 (en) 1997-10-31 2002-08-06 New Horizons Diagnostics Corp Vaginal suppository for treating group B Streptococcus infection
US6423299B1 (en) 1997-10-31 2002-07-23 Vincent Fischetti Composition for treatment of a bacterial infection of an upper respiratory tract
US6056954A (en) 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US6277399B1 (en) 1997-10-31 2001-08-21 New Horizon Diagnostics Corporation Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections
US6432444B1 (en) 1997-10-31 2002-08-13 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymes for treating dermatological infections
US6752988B1 (en) 2000-04-28 2004-06-22 New Horizons Diagnostic Corp Method of treating upper resiratory illnesses
US6406692B1 (en) 1997-10-31 2002-06-18 New Horizons Diagnostics Corp Composition for treatment of an ocular bacterial infection
US6787134B1 (en) 1997-12-19 2004-09-07 Kyowa Hakko Kogyo Co., Ltd. Methods for preventing/remedying mastitis
US6875903B2 (en) 1998-06-22 2005-04-05 University Of Vermont Treatment of Staphylococcus infections
US7091332B1 (en) 1998-06-22 2006-08-15 University Of Vermont Treatment of staphylococcus infections
US6569830B1 (en) 1999-03-05 2003-05-27 Ambi, Inc. Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains
US7063837B2 (en) 1999-09-14 2006-06-20 New Horizons Diagnostics Corp Syrup composition containing phage associated lytic enzymes
JP2002187853A (ja) * 2000-12-21 2002-07-05 Shinei Ferumentekku:Kk 動物の乳頭除菌剤および菌環境改善方法
CN100450546C (zh) * 2002-01-28 2009-01-14 上海高科生物工程有限公司 一种溶葡萄球菌酶复配制剂及其制备方法
CN1322815C (zh) * 2002-11-21 2007-06-27 上海高科生物工程有限公司 一种洗面奶及其制备方法
CN102008455A (zh) * 2010-12-09 2011-04-13 上海高科联合生物技术研发有限公司 一种用于治疗奶牛乳腺炎的冻干粉制剂
US9737047B2 (en) 2011-03-22 2017-08-22 Ccd Holdings Llc Method for the treatment, control, minimization, and prevention of bovine mastitis
US8757092B2 (en) 2011-03-22 2014-06-24 Eco-Composites Llc Animal bedding and associated method for preparing the same
US10151751B2 (en) 2013-12-18 2018-12-11 Asahi Kasei Kabushiki Kaisha Method for detecting Staphylococcus contained in milk

Also Published As

Publication number Publication date
AU623864B2 (en) 1992-05-28
EP0359873B1 (de) 1993-09-15
DE3884200T2 (de) 1994-02-03
EP0359873A1 (de) 1990-03-28
AU2179388A (en) 1990-03-08

Similar Documents

Publication Publication Date Title
DE3884200D1 (de) Verfahren zur Behandlung von Mastitis und anderen Staphylokokkeninfektionen.
ATA907182A (de) Einrichtung zur behandlung von blutgefaessen od.dgl.
DE69307509D1 (de) Vorrichtung zur behandlung von herzfehlern
DE69012592T2 (de) Verfahren zur Hautbehandlung.
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69008820T2 (de) Verfahren zur Behandlung von Polymerisaten.
DE3782214D1 (de) Mittel zur behandlung des scheidenmilieus.
DE59009344D1 (de) Verfahren zur Behandlung von Polyolefinfolien.
DE3765137D1 (de) Verfahren und zusammensetzung zur vorbeugung und behandlung von virus-infektionen.
DE68907569T2 (de) Mittel zur Behandlung oder Vorbeugung von Aids.
DE3885798T2 (de) Proteinhaltiges Polysaccharid zur Behandlung retroviraler Infektionen.
PT77020B (de) Mittel zur behandlung von wunden
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
DE68908445T2 (de) Mittel zur Behandlung von Lebererkrankungen.
DE69112718D1 (de) Verfahren und Zusammensetzung zur Behandlung von tierischen Exkrementen.
ATE71299T1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen.
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
ATE94406T1 (de) Verfahren zur behandlung von mastitis und anderen staphylokokkeninfektionen.
DE68912463D1 (de) Konditionierte insektizide mischungen und verfahren zur insektiziden behandlung.
DE69011065D1 (de) Verfahren zur Behandlung von Nickel-Magnesium-Silikaterzen.
DE3881377T2 (de) Mittel zur prophylaxe und behandlung von thrombocytopenie.
DE59203788D1 (de) Verfahren zur Herstellung und Reinigung von 1-Amino-2-phenoxy-4-hydroxy-anthrachinon.
DE9307108U1 (de) Vorrichtung zur Behandlung von Zahnfehlstellungen
DE68914886T2 (de) Mittel zur Behandlung von Raynaud's Krankheit.
ATE56878T1 (de) Verfahren und zusammensetzung zur vorbeugung und behandlung von virus-infektionen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: JABBUSCH, ARENDT & SIEKMAN, 30161 HANNOVER

8339 Ceased/non-payment of the annual fee